Phakic status affects vitreous penetration of topical moxifloxacin.

Suppr

超能文献

作者信息

Fuller Jeffrey J, McGwin Gerald

出版信息

Arch Ophthalmol. 2006 May;124(5):749; author reply 749. doi: 10.1001/archopht.124.5.749-a.

DOI:10.1001/archopht.124.5.749-a

PMID:16682605

Abstract

摘要

相似文献

Phakic status affects vitreous penetration of topical moxifloxacin.

Arch Ophthalmol. 2006 May;124(5):749; author reply 749. doi: 10.1001/archopht.124.5.749-a.

Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous.

Arch Ophthalmol. 2005 Jan;123(1):39-44. doi: 10.1001/archopht.123.1.39.

Vitreous and aqueous penetration of orally administered moxifloxacin in humans.

Eye (Lond). 2007 Sep;21(9):1242-3; author reply 1243. doi: 10.1038/sj.eye.6702915. Epub 2007 Jul 6.

Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans.

Surv Ophthalmol. 2006 Sep-Oct;51(5):530; author reply 530-1. doi: 10.1016/j.survophthal.2006.06.001.

Vitreous penetration of topical moxifloxacin and gatifloxacin in humans.

Retina. 2006 Feb;26(2):191-5. doi: 10.1097/00006982-200602000-00012.

Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.

Ophthalmology. 2006 Jun;113(6):955-9. doi: 10.1016/j.ophtha.2006.01.061. Epub 2006 Apr 17.

Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device.

J Cataract Refract Surg. 2005 Nov;31(11):2142-6. doi: 10.1016/j.jcrs.2005.04.028.

The effect of cataract surgery on ocular levels of topical moxifloxacin.

Am J Ophthalmol. 2004 Oct;138(4):554-9. doi: 10.1016/j.ajo.2004.05.011.

Vitreous and aqueous penetration of orally administered moxifloxacin in humans.

Arch Ophthalmol. 2006 Feb;124(2):178-82. doi: 10.1001/archopht.124.2.178.

Comparative intraocular penetration of 4 fluoroquinolones after topical instillation.

Cornea. 2013 Jul;32(7):1046-51. doi: 10.1097/ICO.0b013e31828d6d9e.

引用本文的文献

Moxifloxacin and bilateral acute iris transillumination.

J Ophthalmic Inflamm Infect. 2013 Jan 14;3(1):10. doi: 10.1186/1869-5760-3-10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Phakic status affects vitreous penetration of topical moxifloxacin.

Arch Ophthalmol. 2006 May;124(5):749; author reply 749. doi: 10.1001/archopht.124.5.749-a.

Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous.

Arch Ophthalmol. 2005 Jan;123(1):39-44. doi: 10.1001/archopht.123.1.39.

Vitreous and aqueous penetration of orally administered moxifloxacin in humans.

Eye (Lond). 2007 Sep;21(9):1242-3; author reply 1243. doi: 10.1038/sj.eye.6702915. Epub 2007 Jul 6.

Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans.

Surv Ophthalmol. 2006 Sep-Oct;51(5):530; author reply 530-1. doi: 10.1016/j.survophthal.2006.06.001.

Vitreous penetration of topical moxifloxacin and gatifloxacin in humans.

Retina. 2006 Feb;26(2):191-5. doi: 10.1097/00006982-200602000-00012.

Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.

Ophthalmology. 2006 Jun;113(6):955-9. doi: 10.1016/j.ophtha.2006.01.061. Epub 2006 Apr 17.

Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device.

J Cataract Refract Surg. 2005 Nov;31(11):2142-6. doi: 10.1016/j.jcrs.2005.04.028.

The effect of cataract surgery on ocular levels of topical moxifloxacin.

Am J Ophthalmol. 2004 Oct;138(4):554-9. doi: 10.1016/j.ajo.2004.05.011.

Vitreous and aqueous penetration of orally administered moxifloxacin in humans.

Arch Ophthalmol. 2006 Feb;124(2):178-82. doi: 10.1001/archopht.124.2.178.

Comparative intraocular penetration of 4 fluoroquinolones after topical instillation.

Cornea. 2013 Jul;32(7):1046-51. doi: 10.1097/ICO.0b013e31828d6d9e.

引用本文的文献

Moxifloxacin and bilateral acute iris transillumination.

J Ophthalmic Inflamm Infect. 2013 Jan 14;3(1):10. doi: 10.1186/1869-5760-3-10.